湖岸生物上涨8.58%，报0.82美元/股，总市值3379.44万美元

Core Insights - Lakeshore Bio (LSB) opened with an increase of 8.58%, reaching $0.82 per share, with a total market capitalization of approximately $33.79 million [1] - As of September 30, 2024, Lakeshore Bio reported total revenue of 372 million RMB, representing a year-on-year growth of 36.2% [1] - The net profit attributable to the parent company was 20.58 million RMB, showing a significant year-on-year increase of 111.79% [1] Company Overview - Lakeshore Bio Technology Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operated by its domestic subsidiary, Beijing Yisheng Biotechnology Co., Ltd. [1] - Beijing Yisheng Biotechnology Co., Ltd. is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer [1]